A Phase I, Multi-Centre, Open-Label, Fixed-Sequence Study to Assess the Pharmacokinetics of Methotrexate Alone and When Co-Administered With AZD9056 in Subjects With Rheumatoid Arthritis.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2010
At a glance
- Drugs AZD 9056; Methotrexate
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 02 Dec 2010 Trilal location (Germany) identified as reported by ClinicalTrials.gov.
- 02 Dec 2010 Planned end date changed to 1 Sep 2009 as reported by ClinicalTrials.gov.
- 23 Jun 2009 New trial record